🧬 Targeting two key pathways in cancer.
A new study in hLife reports potent, broad-spectrum antitumor activity of the EGFR/c-MET bispecific antibody ALK101.

🧬 Targeting two key pathways in cancer.
A new study in hLife reports potent, broad-spectrum antitumor activity of the EGFR/c-MET bispecific antibody ALK101.
🧬 Driving the future of human immunology
A new Dialogue in hLife with Professor Miriam Merad, exploring myeloid cell biology, translational immunology, and the future of human immunology.
🧬 Metaproteomics of the Microbiome
Join us for live talks on the gut microbiome, metaproteomics, microbial ecosystem dynamics, and stress responses.
đź“… Sept 21 | 09:00 (GMT+8)
🎥 Scan the QR code to reserve your spot!
#Microbiome #Metaproteomics #hLife